Arcturus Therapeutics Holdings, Inc. (ARCT)
7.16
+0.04
(+0.56%)
USD |
NASDAQ |
Jun 09, 16:00
7.16
0.00 (0.00%)
After-Hours: 20:00
Arcturus Therapeutics Holdings SG&A Expense (Quarterly) : 9.465M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Ionis Pharmaceuticals, Inc. | 150.36M |
| Oncotelic Therapeutics, Inc. | 1.853M |
| Enanta Pharmaceuticals, Inc. | 9.568M |
| Veracyte, Inc. | 50.84M |